Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Growth Horm IGF Res. 2012 Apr 30;22(0):108–115. doi: 10.1016/j.ghir.2012.04.001

Figure 5. InsR isoform expression of ER+, ER−, and HR ER+ breast tumors.

Figure 5

Figure 5

Figure 5

Figure 5

Data are graphed as a median within a 50% interquartile range box plot with whiskers extending from 10–90% of the reported data range. (A) Cumulative and isoform specific InsR expression of FFPE breast tumors. (B) InsR isoform expression of FFPE tumor ER subgroups. (C) InsR isoform expression ratios. (D) IGF-1R expression of HR ER+ breast tumors. +++p<0.0001,***p<0.0005, * p<0.05

HHS Vulnerability Disclosure